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Abstract:  
Background and objective: The immune system is an important player in the pathophysiology of periodontitis. The brain 
controls immune responses via neural and hormonal pathways, and brain-neuro-endocrine dysregulation may be a central 
determinant for pathogenesis. Our current knowledge also emphasizes the central role of sensory nerves. In line with this, 
we wanted to investigate how desensitization of peptidergic sensory neurons influences the progression of ligature-
induced periodontitis, and, furthermore, how selected cytokine and stress hormone responses to Gram-negative bacterial 
lipopolysaccharide (LPS) stimulation are affected.  
Material and methods: Resiniferatoxin (RTX; 50 μg/kg) or vehicle was injected subcutaneously on days 1, 2, and 3 in 
stress high responding and periodontitis-susceptible Fischer 344 rats. Periodontitis was induced 2 days thereafter. Progres-
sion of the disease was assessed after the ligatures had been in place for 20 days. Two h before decapitation all rats re-
ceived LPS (150 μg/kg i.p.) to induce a robust immune and stress response.  
Results: Desensitization with RTX significantly reduced bone loss as measured by digital X-rays. LPS provoked a signifi-
cantly higher increase in serum levels of the pro-inflammatory cytokine tumour necrosis factor (TNF)- , but lower serum 
levels of the anti-inflammatory cytokine interleukin (IL)-10 and the stress hormone corticosterone.  
Conclusions: In this model RTX-induced chemical desensitization of sensory peptidergic neurons attenuated ligature-
induced periodontitis and promoted a shift towards stronger pro-inflammatory cytokine and weaker stress hormone re-
sponses to LPS. The results may partly be explained by the attenuated transmission of immuno-inflammatory signals to 
the brain. In turn, this may weaken the anti-inflammatory brain-derived pathways. 
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INTRODUCTION  
Understanding the complex pathophysiology of perio-
dontitis continues to be a major challenge in clinical and 
experimental research. Recognition of microorganisms and 
subsequent activation of innate and adaptive components of 
the immune system are essential for resistance to infectious 
and inflammatory diseases [1]. Sensory peptidergic nerves 
are major regulators of immune/inflammatory reactions, and 
the number of identified bioactive neuropeptides is ever-
increasing [2, 3]. Via neural and hormonal pathways the 
brain controls and regulates many of these immune re-
sponses, and dysregulation of the overarching regulatory 
pathways may play a significant role for susceptibil-
ity/resistance to infectious and inflammatory diseases [4-12].  
Cells of the innate immune system express pattern recog-
nition receptors (PRRs) that detect invariant molecular struc- 
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tures on microorganisms, including Toll-like receptors 4 
(TLR4) that sense lipopolysaccharide (LPS) on Gram-
negative bacteria [13]. When such pathogen-associated mo-
lecular patterns (PAMPs) are perceived, distinct intracellular 
pathways are activated. Expression of a wide variety of 
genes ultimately results in production and secretion of im-
mune mediators, including pro- and anti-inflammatory cyto-
kines. These and a number of other immune mediators are of 
critical importance in co-ordinating innate and adaptive im-
munity, whose cooperative interactions enable the immune 
system to recognize, eliminate, and control pathogens with 
maximal efficacy and minimal damage to surrounding tis-
sues [13]. In addition, LPS is directly and indirectly (via 
immune mediators) sensed by terminals of a subpopulation 
of primary afferent sensory nerves (capsaicin-sensitive 
nerves) that release several neuropeptides with immunoregu-
latory properties, such as substance P, calcitonin gene-related 
peptide, and somatostatin, from peripheral nerve terminals at 
the site of inflammation [14], as well as transmit information 
to the brain [15, 16].  
Stimulation of the sensory nerves with LPS or immune 
mediators is, among others, conveyed to the parvocellular 
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neurons within the paraventicular nucleus of the hypothala-
mus and neurons in the locus coeruleus, which in turn acti-
vates the hypothalamic-pituitary-adrenal (HPA) axis and the 
sympathetic nervous system (SNS) [3, 11]. The subsequent 
release of glucocorticoid hormones and catecholamines regu-
late a number of immune system responses whose main ef-
fect is to down-regulate pro-inflammatory and up-regulate 
anti-inflammatory responses [3, 7, 8, 10]. LPS may also act 
upon the parasympathetic nervous system (PSNS). Like the 
HPA axis and SNS it has anti-inflammatory properties, 
mostly due to liberated acetylcholine [7]. These brain-
controlled regulatory pathways strive to skew immune re-
sponses towards the anti-inflammatory side and thus impor-
tantly determines the natural course of infectious and in-
flammatory diseases.  
Our previous research has revealed that the reactivity of 
the HPA axis, SNS and PSNS vitally influences the suscep-
tibility and resistance to periodontitis [17-27]. Until now it 
has not been demonstrated if and how the sensory peptider-
gic nervous system can modulate the clinical course of pe-
riodontitis. Due to the effect on the non-selective cation 
channel “transient receptor potential vanilloid 1” (TRPV1), 
high systemic doses of capsaicin, or the much more potent 
capsaicin analogue resiniferatoxin (RTX), reduce or abolish 
the sensitivity of these nerves in rodents [15, 28-31]. Since 
LPS and LPS-induced immune mediators stimulate periph-
eral sensory peptidergic nerve terminals to release neuropep-
tides at the site of inflammation, and peripheral sensory 
nerve activation generates signals to the brain and activates 
efferent anti-inflammatory pathways, experimental sensory 
peptidergic desensitization may also be used to examine how 
the sensory peptidergic nervous system reacts to exogenous 
stimulants like LPS to modulate the disease process. To po-
tentially elucidate mechanisms, we have included measure-
ment of selected pro- and anti-inflammatory cytokines as 
well as the HPA axis-derived hormone corticosterone after a 
systemic challenge with LPS.  
MATERIAL AND METHODS 
Animals 
Twenty male Fischer 344 rats, weighing 250-260 g, were 
obtained from Möllegaard Breeding Center (Ejby, Denmark) 
and used after 2 weeks of acclimatisation. Fischer 344 rats 
were used because our previous experiments have revealed 
that compared to histocompatible and stress low responding 
Lewis rats, these stress high responding animals are highly 
susceptible to periodontitis [17, 18, 32]. Standard rat chow 
pellets and tap water were available ad libitum. The animals 
were housed in groups of five under a 12/24 h light/dark 
cycle (light on from 7.00 a.m. to 7.00 p.m.) with temperature 
and humidity at 22 °C and 40-60 %, respectively. The ex-
periments were registered and approved by the Norwegian 
Experimental Animal Board (NEAB).  
Chemical Desensitization of Sensory Peptidergic Neurons 
with Resiniferatoxin 
Systemic chemical desensitization of sensory peptidergic 
neurons was induced with RTX 50 μg/kg (Sigma-Aldrich, 
St. Louis, MO, USA,) [14]. RTX was dissolved in absolute 
ethanol to make a 1 mg/ml stock solution and was further 
diluted with saline. One group of animals (n = 10) was in-
jected subcutaneously with this solution once daily on three 
consecutive days in doses of 50 μg/kg body weight. The con-
trols (n = 10) received vehicle (ethanol diluted with saline) 
only. The success of RTX treatment was controlled by the 
“wiping test” [14]. In short, 100 g/ml 100 l of capsaicin 
solution was placed onto the cornea and the number of eye 
wipes was counted for 1 min. None of the desensitized ani-
mals showed wiping behaviour.  
Experimental Periodontal Disease 
Two days after the last injection of RTX, all animals 
were anaesthetised with a subcutaneous injection of Hyp-
norm-Dormicum (fentanyl/fluanizone, midazolam; Janssen 
and Cilag, Saunderton, U.K.) 0.2 ml/100g body weight. A 
sterile silk ligature (Ethicon Perma-hand® size 3/0, Nor-
derstedt, Germany) was tied around the neck of the maxillary 
right 2nd molar tooth in the gingival sulcus. The ligatures 
served as a retention device for oral microorganisms. Twenty 
days after application of the ligatures, all animals were killed 
by decapitation. The maxillae were excised and fixed in 4 % 
formaldehyde. 
Lipopolysaccaride Challenge 
To assess whether the treatment regimen influenced cy-
tokine or corticosterone responses, all animals were injected 
with LPS (E.coli serotype 0111:B4, Sigma-Aldrich, St. 
Louis, MO, USA) 150 μg/kg intraperitoneally 2 h before 
ending the experiments. After decapitation of the rats, blood 
samples were collected (6 - 10 ml from each animal) in vacu-
tainer tubes (10 ml without additives) and allowed to clot on 
ice for 1 h. Thereafter, the samples were centrifuged for 20 
min at 2000 x g. The serum samples were removed, ali-
quoted and stored at 20 °C prior to analysis.  
Assay of Serum TNF- , IL-10, and Transforming 
Growth Factor (TGF)-1  
The concentrations of TNF- , TGF-1 , and IL-10 were 
measured by means of enzyme-linked immunosorbant assays 
(ELISA) kits (R&D systems, Inc., Minneapolis, MN, USA) 
with catalogue numbers RAT00 for TNF- , MB100 for 
TGF-1 , and R1000 for IL-10. The minimum detectable 
concentration for TNF-  was less than 12.5 pg/ml, and less 
than 31.2 pg/ml for TGF-1  and IL-10. 
Corticosterone Assay 
Corticosterone was measured with 125I radioimmunoas-
say (RIA) coat-A-count kit from Diagnostic Products Corpo-
ration, Los Angeles, CA, USA, catalogue number TKRC1. 
The detection limit was 5.7 ng/ml.  
Radiographic Examination 
The specimens were stabilised with dental wax on a 
Sidexis digital X-ray sensor, orientated with the axis of the 
teeth parallel to the sensor surface by using 4x magnification 
loupe glasses (Zeiss, Norstedt, Germany). The distance be-
tween the cemento-enamel junction and bone on mesial sur-
faces of the 2nd molars was displayed digitally. The exami-
nation was done blinded. Each X-ray was read three times, 
and the mean of the three readings calculated. The reliability 
of the method has been tested earlier [17]. Bone loss as 
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measured with digital X-rays was chosen as an indicator of 
the severity of periodontitis because our previous studies 
have shown that this measurement is significantly more reli-
able than measuring periodontal fibre loss and bone loss on 
histological sections [17-22].  
Statistics 
Data are presented as mean ± SEM. The data were tested 
for normal distribution. Thereafter differences between val-
ues were estimated with t-test or Mann-Whitney Rank Sum 
Test, as appropriate. p-values less than 0.05 were considered 
statistically significant.  
RESULTS 
Effect of Resiniferatoxin Pre-Treatment on the Weight of 
the Animals 
The RTX-treated and control animals weighed 254.1 ± 
7.6 g and 252.9 ± 8.5 g (p = 0.69), respectively, at RTX in-
duction, and 281.0 ± 12.3 g and 304.2 ± 11.4 g (p < 0.01), 
respectively, at the end of the experiments.  
Effect of resiniferatoxin pre-treatment on periodontal tis-
sue destruction 
The RTX-treated animals had significantly less alveolar 
bone loss than the controls (615 ± 22 m vs. 700 ± 15 m; p 
< 0.01; Fig. 1). Since the RTX-treated rats weighed less, the 
length of their teeth could be shorter. We therefore compared 
the root-length of the right 2nd molar teeth in the two groups 
by measuring the distance between the cemento-enamel 
junction (CEJ) and apex on mesial root surfaces. There was 
no difference between the root-length in the RTX- and sa-
line-treated control rats.  
Effects of Resiniferatoxin Pre-Treatment on Selected Se-
rum Cytokines after LPS Challenge 
After LPS challenge RTX-treated rats tended to react 
with higher TNF-  serum levels than vehicle-treated control 
rats (6052 ± 1307 ng/ml vs. 2934 ± 177 ng/ml; p = 0.055); 
(Fig. 2A). The serum levels of IL-10 were significantly 
lower in the RTX-treated rats compared with vehicle-treated 
controls.  
(114 ± 12 pg/ml vs. 197 ± 12 pg/ml; p < 0.001; Fig. 2B). 
The values for TGF-1  did not differ between the groups 
(50.1 ± 1.1 ng/ml vs. 52.8 ± 1.2 ng/ml, p = 0.12).  
Effects of Resiniferatoxin Pre-Treatment on Corticoster-
one Plasma Levels after LPS Challenge 
Treatment with RTX significantly reduced the HPA axis 
response to LPS as measured by serum corticosterone (1504 
± 253 nmol/l vs. 2180 ± 41 nmol/l; p = 0.04; Fig. 3).  
DISCUSSION 
The rationale for performing the present study was previ-
ous research showing that the reactivity of brain-controlled 
immunoregulatory systems plays a significant role in the 
susceptibility and resistance to periodontitis, principally due 
to the effects on immune responses [17-27, 32]. We have 
  
Fig. (1). The mean distance from the cemento-enamel junction to 
the alveolar bone crest in resiniferatoxin-treated rats, and vehicle-
treated control rats as measured on digital radiographs. (* p < 0.01 
vs. controls). 
 
Fig. (2). A-B. Serum levels of the pro-inflammatory cytokine tumour necrosis factor (TNF)-  (A), and the anti-inflammatory cytokine inter-
leukin (IL)-10 (B) 2 h after intraperitoneal injection of LPS (150 μg/kg) in resiniferatoxin-treated rats and vehicle-treated control rats. Res-
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now expanded these results and shown that inhibition of sen-
sory peptidergic neurons strengthens the resistance to liga-
ture-induced periodontitis. The treatment also tended to 
boost the pro-inflammatory TNF-  serum levels after a ro-
bust in vivo LPS challenge, while at the same time inhibiting 
the anti-inflammatory cytokine IL-10 and the HPA axis-
derived hormone corticosterone. The results support other 
recent in vivo studies demonstrating a pro-inflammatory role 
of sensory peptidergic neuron inhibition [14, 33, 34]. Fur-
thermore, they suggest that the immune system influences 
the vulnerability to periodontitis in such a way that a 
stronger systemic TNF-  and a weaker HPA axis response 
ameliorates the clinical course of periodontitis [17-26]. To 
our knowledge, this is the first report showing that the auto-
nomic sensory peptidergic nervous system, via the mecha-
nisms outlined above, may be involved in the pathogenesis 
of periodontitis.  
Increased colonization or over-growth of pathogenic mi-
croorganisms in the subgingival dental biofilm, including the 
Gram-negative Porphyromonas gingivalis, is commonly held 
to be responsible for initiating periodontitis [35]. This may 
indicate that adaptive immune system responses vital for 
clearing these pathogens are inappropriately regulated. It is 
also supported by our previous experimental studies in ro-
dents showing that modulation of adaptive immune re-
sponses with agents that drive T helper 1 (Th1) and T regula-
tory (Treg) responses inhibits periodontitis [36, 37]. Other 
investigations may indicate that immune responses are dys-
regulated in patients with severe periodontitis [38-40]. The 
tissue injury itself seems to be caused by excessive recruit-
ment and activation of cells belonging to the innate immune 
system, in particular polymorphonuclear phagocytes 
(PMNs), and subsequent release of tissue destructive media-
tors like reactive oxygen species and proteolytic enzymes 
[41-47].  
Based on data from previous experiments, we have 
pointed out that periodontitis may be the result of a dysregu-
lated brain-neuro-endocrine balance that reduces the ability 
of adaptive immunity to clear colonizing periodontopatho-
gens. A chronic over-activity of the innate immune system 
may protect the gingival tissues as well as the entire organ-
ism from infection by these pathogens [25-27]. Thus, accord-
ing to our hypothesis, periodontitis is not a result of failure to 
remove PMNs and their products from the inflammatory 
sites, as stated by other investigators [45], but rather a hidden 
benefit that protects the organism from infection of patho-
genic dental plaque microorganisms during an inappropriate 
adaptive immune response.  
It is well known that brain-controlled neurotransmitters 
and neuropeptides released from nerve terminals participate 
in local and systemic immuno-inflammatory reactions to 
infection or trauma [2, 7, 14]. Capsaicin and RTX have the 
unique property to excite or stimulate a subset of the sen-
sory/peptidergic neurons when given in low doses, but to 
inhibit or block their function when given in repeated or high 
doses [15, 28, 29]. This desensitization of sensory peptider-
gic nerves may be caused by interaction with the TRPV1 
receptor, a non-selective cation channel that is typically acti-
vated by noxious heat, acid or low pH, certain lipids, chemi-
cal irritants, and inflammatory mediators [28, 48]. TLR4 is 
co-expressed with TRPV1 on sensory peptidergic nerve ter-
minals [16]. Thus, sensory peptidergic neurons may be able 
to respond both to inflammatory mediators and directly to 
constituents like LPS of Gram-negative bacteria. Pre-
treatment with high and/or repeated doses of capsaicin or 
RTX eliminates this property, and local release of neuropep-
tides as well as afferent signals to the brain are discontinued 
[28, 48]. While the former should reduce inflammation, the 
latter would be expected to have the opposite effect. The net 
result of desensitization on the inflammatory response could 
therefore lean in either direction.  
Originally, the neuropeptides from the sensory peptider-
gic nerve endings have been looked upon as primarily pro-
inflammatory, but recent research has shown that they vary 
in their profile of action. Substance P is known to be a potent 
vasodilator, increasing vascular permeability and stimulating 
many pro-inflammatory processes, including LPS-induced 
TNF-  production and release [49, 50]. Calcitonin gene-
related peptide and somatostatin, on the other hand, inhibit 
TNF-  [51-53]. In our in vivo study, the RTX-treated ani-
mals reacted towards a stronger TNF-  response to systemic 
LPS stimulation. We did not measure cytokine responses in 
gingival connective tissues in this experiment, but other in-
vestigations have also shown more powerful local inflamma-
tory reactions and pro-inflammatory cytokine responses to 
LPS stimulation after RTX treatment [14]. This indicates 
that anti-inflammatory rather than pro-inflammatory path-
ways are inhibited by the RTX-induced inhibition of sensory 
peptidergic neurons. In line with this, it has recently been 
demonstrated that the TRPV1 agonist SA13353 inhibits 
LPS-induced TNF-  production in vivo [34]. An alternative 
explanation for the observed cytokine pattern implies that 
RTX may selectively inhibit the release of anti-inflammatory 
neuropeptides. The anti-inflammatory effect of calcitonin 
gene-related peptide and/or somatostatin release thus should 
outweigh the pro-inflammatory effect of Substance P release. 
Results from other investigators may be taken in favour of 
such an interpretation [14, 34].  
 
Fig. (3). Serum corticosterone levels 2 h after intraperitoneal injec-
tion of LPS (150 μg/kg) in resiniferatoxin-treated rats and vehicle-
treated control rats. Compared to control rats, resiniferatoxin-
treated rats showed significantly lower serum levels of corticoster-
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The present experiments may also suggest that over-
activation of the sensory peptidergic nervous system could 
cause a converse outcome. Interestingly, severe anxiety and 
major depression of the melancholic type has been found to 
increase the susceptibility to periodontitis in both humans 
and animal studies [26, 32, 54, 55], and chronic hyperactiv-
ity of the HPA axis and the sensory peptidergic nervous sys-
tem is also a typical feature of these emotional conditions [3, 
56, 57]. It is also of interest to note that non-steroidal anti-
inflammatory drugs (NSAIDs) and cyclooxygenase 2 (COX-
2) inhibitors (Coxibs) inhibit periodontitis [58], and both 
classes of drugs suppress pain by inhibiting prostaglandin 
metabolites to activate the recently identified excitatory ion 
channel, transient receptor potential A1 (TRPA1) [59]. Inci-
dentally, this receptor is co-expressed with the capsaicin 
receptor TRPV1 on primary sensory peptidergic neurons 
[59]. In addition, prostagandins, like pro-inflammatory cyto-
kines and LPS, stimulate the HPA axis [60]. Thus, the pro-
tective effect of NSAIDs and Coxibs may in part be a result 
of reduced ability of the sensory peptidergic nervous system 
to signal and stimulate efferent brain controlled anti-
inflammatory pathways, including the HPA axis. Based on 
this, one might speculate that chronic pain, e.g. in patients 
with pro-inflammatory autoimmune diseases like rheumatoid 
arthritis, may be a risk factor for developing severe perio-
dontitis. Differences in pain experience may help us to un-
derstand why some investigators have found a negative [61], 
while others have found a positive association between pe-
riodontitis and rheumatoid arthritis [62]. Experimental ani-
mal studies as well as epidemiological studies are therefore 
needed to investigate the consequences of these putative risk 
factors. 
CONCLUSION 
Taken together, our principal finding is that inhibition or 
complete suppression of the sensory peptidergic nervous 
system with RTX significantly increases the resistance to 
ligature-induced periodontitis. The treatment also tended to 
promote a shift towards a stronger pro-inflammatory TNF- , 
and a significantly weaker anti-inflammatory IL-10 and 
HPA-axis response to an in vivo challenge with LPS. To-
gether with our previous research these data may help us to 
understand how differences in the reactivity of neural and 
hormonal pathways may influence the susceptibility to pe-
riodontitis.  
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